IASO-782 in Autoimmune Hematological Diseases

NCT06534021 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Thrombocytopenia
Warm Autoimmune Haemolytic Anaemia

Interventions

DRUG: IASO-782 injection
DRUG: placebo

Sponsor

Shanghai IASO Biotechnology Co., Ltd